David K Menon Selected Research

Craniocerebral Trauma (Head Injury)

5/2022	Effects of brain tissue oxygen (PbtO2) guided management on patient outcomes following severe traumatic brain injury: A systematic review and meta-analysis.
12/2021	Metabolic derangements are associated with impaired glucose delivery following traumatic brain injury.
1/2021	Outcome Prediction after Moderate and Severe Traumatic Brain Injury: External Validation of Two Established Prognostic Models in 1742 European Patients.
7/2017	Focally perfused succinate potentiates brain metabolism in head injury patients.
10/2015	External Validation and Recalibration of Risk Prediction Models for Acute Traumatic Brain Injury among Critically Ill Adult Patients in the United Kingdom.
8/2012	Continuous determination of optimal cerebral perfusion pressure in traumatic brain injury.
7/2011	Validation of reference tissue modelling for [11C]flumazenil positron emission tomography following head injury.
10/2009	Prediction of outcome in severe traumatic brain injury.
1/2009	A combined microdialysis and FDG-PET study of glucose metabolism in head injury.
1/2008	Nitric oxide in acute brain injury: a pilot study of NO(x) concentrations in human brain microdialysates and their relationship with energy metabolism.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David K Menon Research Topics

Disease

94	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2022 - 04/2004
25	Craniocerebral Trauma (Head Injury) 05/2022 - 05/2002
19	Brain Injuries (Brain Injury) 01/2022 - 08/2002
11	Intracranial Hypertension 01/2022 - 04/2008
8	Critical Illness (Critically Ill) 01/2022 - 01/2004
8	Down Syndrome (Down's Syndrome) 01/2022 - 07/2011
8	Wounds and Injuries (Trauma) 12/2020 - 01/2014
6	Cognitive Dysfunction 01/2021 - 03/2011
6	Hyperventilation 01/2021 - 02/2002
6	Ischemia 01/2020 - 02/2004
5	COVID-19 05/2022 - 01/2020
5	Stroke (Strokes) 02/2022 - 07/2006
5	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 07/2011
4	Disease Progression 01/2022 - 01/2017
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 06/2013
4	Consciousness Disorders 01/2021 - 10/2019
4	Coma (Comas) 01/2020 - 06/2010
4	Atrophy 12/2019 - 01/2017
4	Contusions 10/2015 - 11/2003
3	Brain Ischemia (Cerebral Ischemia) 05/2022 - 02/2007
3	Pain (Aches) 11/2021 - 01/2013
3	Hypothermia 01/2021 - 01/2011
3	Brain Concussion (Cerebral Concussion) 01/2020 - 01/2017
3	Infections 01/2020 - 02/2011
3	Hypoxia (Hypoxemia) 01/2020 - 04/2007
3	Edema (Dropsy) 10/2015 - 02/2011
2	Venous Thromboembolism 01/2022 - 01/2018
2	Unconsciousness (Loss of Consciousness) 01/2021 - 10/2019
2	Hemorrhage 10/2020 - 01/2019
2	Heart Arrest (Cardiac Arrest) 10/2020 - 01/2016
2	Brain Hypoxia (Cerebral Hypoxia) 01/2020 - 04/2007
2	Dementia (Dementias) 12/2019 - 07/2011
2	Hyperalgesia 10/2019 - 01/2013
2	Parkinson Disease (Parkinson's Disease) 04/2016 - 04/2004
2	Schizophrenia (Dementia Praecox) 04/2016 - 06/2008
2	Persistent Vegetative State (Vegetative State) 01/2016 - 01/2012
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 06/2015 - 05/2014
2	Amyloid angiopathy 01/2015 - 01/2014
2	Cerebral Hemorrhage 01/2015 - 05/2014
2	Acute Subdural Hematoma 05/2014 - 01/2013
2	Sepsis (Septicemia) 02/2011 - 01/2005
2	Necrosis 02/2011 - 04/2007
2	Closed Head Injuries 11/2010 - 02/2007
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 05/2022
1	Brain Edema (Cerebral Edema) 01/2022

Drug/Important Bio-Agent (IBA)

22	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2011
21	Oxygen (Dioxygen)IBA 05/2022 - 06/2002
13	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2002
12	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 10/2021 - 05/2002
11	Amyloid (Amyloid Fibrils)IBA 01/2022 - 07/2011
8	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 01/2008
7	Glial Fibrillary Acidic ProteinIBA 01/2022 - 01/2016
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2008
7	Pharmaceutical PreparationsIBA 01/2022 - 06/2008
6	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2022 - 07/2011
6	Pyruvic Acid (Pyruvate)IBA 01/2022 - 01/2008
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 02/2006
5	CytokinesIBA 01/2017 - 10/2007
4	Methylphenidate (Ritalin)FDA LinkGeneric 01/2021 - 01/2017
4	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2016 - 10/2007
3	Biological ProductsIBA 01/2022 - 06/2010
3	Succinic Acid (Succinate)IBA 01/2022 - 07/2017
3	Oxygen-15IBA 12/2021 - 01/2006
3	Carbon DioxideIBA 01/2021 - 06/2002
3	Amyloid beta-PeptidesIBA 12/2019 - 01/2017
3	Propofol (Diprivan)FDA LinkGeneric 10/2019 - 08/2003
3	Adenosine Monophosphate (AMP)IBA 04/2018 - 12/2017
3	Hemoglobins (Hemoglobin)IBA 01/2018 - 11/2010
3	Ubiquitin CIBA 01/2017 - 03/2016
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 05/2004 - 01/2004
3	Dopamine (Intropin)FDA LinkGeneric 05/2004 - 01/2004
2	ChemokinesIBA 01/2022 - 01/2016
2	Blood Proteins (Serum Proteins)IBA 01/2022 - 01/2017
2	Protein Isoforms (Isoforms)IBA 11/2021 - 01/2020
2	AutoantibodiesIBA 01/2021 - 01/2016
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 01/2020
2	Tranexamic Acid (AMCA)FDA Link 01/2020 - 10/2019
2	Analgesics (Analgesic Drugs)IBA 10/2019 - 01/2013
2	Hemostatics (Antihemorrhagics)IBA 01/2018 - 06/2013
2	Neurotransmitter Agents (Neurotransmitter)IBA 04/2016 - 03/2011
2	fluoromisonidazoleIBA 01/2016 - 04/2007
2	Blood Glucose (Blood Sugar)IBA 02/2015 - 10/2004
2	CarbonIBA 01/2014 - 07/2011
2	SolutionsIBA 02/2011 - 01/2008
2	BenzodiazepinesIBA 02/2011 - 07/2006
2	AlbuminsIBA 06/2010 - 04/2008
2	Glutamic Acid (Glutamate)FDA Link 01/2008 - 06/2002
1	Factor V (Coagulation Factor V)IBA 03/2022
1	Messenger RNA (mRNA)IBA 03/2022
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2022

Therapy/Procedure

24	Critical Care (Surgical Intensive Care) 05/2022 - 05/2002
16	Therapeutics 01/2021 - 02/2002
13	Decompressive Craniectomy 01/2022 - 01/2011
6	Length of Stay 12/2020 - 01/2006
5	Catheters 01/2019 - 01/2008
3	Craniotomy 01/2022 - 09/2012
3	Resuscitation 10/2020 - 04/2011
3	Erythrocyte Transfusion 09/2019 - 03/2009
2	Patient Discharge 02/2022 - 09/2020
2	Artificial Respiration (Mechanical Ventilation) 12/2020 - 05/2002